Hyper-progressive disease in patients with advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo)

被引：0
|
作者：
Costantini, Adrien [1 ]
Corny, Jennifer [2 ]
Fallet, Vincent [1 ]
Renet, Sophie [2 ]
Friard, Sylvie [3 ]
Chouaid, Christos [4 ]
Duchemann, Boris [5 ]
Giroux-Leprieur, Etienne [6 ]
Taillade, Laurent [7 ]
Doucet, Ludovic [8 ]
Nguenang, Marina [9 ]
Jouveshomme, Stephane [10 ]
Wislez, Marie [1 ]
Tredaniel, Jean [10 ]
Cadranel, Jacques [1 ]
机构：
[1] Hop Tenon, Serv Pneumol, Paris, France
[2] Grp Hosp Paris St Joseph, Pharm Clin, Paris, France
[3] Hop Foch, Serv Pneumol, Suresnes, France
[4] Ctr Hosp Intercommunal Creteil, Serv Pneumol, Creteil, France
[5] Hop Avicenne, Serv Oncol Med, Bobigny, France
[6] Hop Ambroise Pare, Serv Pneumol & Oncol, Boulogne Billancourt, France
[7] Hop La Pitie Salpetriere, Serv Oncol Med, Paris, France
[8] Hop St Louis, Serv Oncol Med, Paris, France
[9] Hop Bichat Claude Bernard, Serv Pneumol C, Paris, France
[10] Grp Hosp Paris St Joseph, Serv Pneumol, Paris, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA2808
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2808
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease
    Soo Han Kim
    Chang-Min Choi
    Dae Ho Lee
    Sang-We Kim
    Shinkyo Yoon
    Woo Sung Kim
    Wonjun Ji
    Jae Cheol Lee
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 3025 - 3036
  • [2] Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease
    Kim, Soo Han
    Choi, Chang-Min
    Lee, Dae Ho
    Kim, Sang-We
    Yoon, Shinkyo
    Kim, Woo Sung
    Ji, Wonjun
    Lee, Jae Cheol
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (11) : 3025 - 3036
  • [3] Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo).
    Costantini, Adrien
    Julie, Catherine
    Dumenil, Coraline
    Helias-Rodzewicz, Zofia
    Dumoulin, Jennifer
    Giraud, Violaine
    Labrune, Sylvie
    Chinet, Thierry
    Emile, Jean-Francois
    Giroux-Leprieur, Etienne
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Analysis of genetic alterations related to hyper-progressive disease after immunotherapy in patients with non-small cell lung cancer
    Xiang, Xudong
    Zhang, Hushan
    Wang, Deguang
    Li, Heng
    Lei, Qing
    Ma, Qianli
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Evaluation of disease-related symptoms in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC) treated with nivolumab (NIVO) or docetaxel (DOC)
    Gralla, R. J.
    Coon, C.
    Taylor, F.
    Penrod, J. R.
    DeRosa, M.
    Dastani, H.
    Orsini, L.
    Reck, M.
    Oncology Research and Treatment, 2015, 38 : 14 - +
  • [6] Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer
    Takatoshi Enomoto
    Akihiro Tamiya
    Kinnosuke Matsumoto
    Yuichi Adachi
    Koji Azuma
    Yuji Inagaki
    Shunichi Kouno
    Yoshihiko Taniguchi
    Nobuhiko Saijo
    Kyoichi Okishio
    Shinji Atagi
    Clinical and Translational Oncology, 2021, 23 : 582 - 590
  • [7] Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer
    Enomoto, T.
    Tamiya, A.
    Matsumoto, K.
    Adachi, Y.
    Azuma, K.
    Inagaki, Y.
    Kouno, S.
    Taniguchi, Y.
    Saijo, N.
    Okishio, K.
    Atagi, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (03): : 582 - 590
  • [8] Long-term survival outcomes with Nivolumab (Nivo) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response
    Wohlleber, M.
    Brahmer, J.
    Borghaei, H.
    Ramalingam, S. S.
    Horn, L.
    de Castro Carpeno, J.
    Pluzanski, A.
    Burgio, M. A.
    Garassino, M.
    Chow, L. Q. M.
    Gettinger, S.
    Crino, L.
    Planchard, D.
    Butts, C.
    Drilon, A.
    Wojcik-Tomaszewska, J.
    Otterson, G.
    Agrawal, S.
    Li, A.
    Penrod, J. R.
    Antonia, S. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 110 - 110
  • [9] Advanced non-small cell Lung Cancer (NSCLC) Nivolumab in advanced NSCLC with Squamous Epithelial Histology
    Sankawa, Yuri
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (03) : 149 - 149
  • [10] Long-term outcomes with nivolumab in patients with previously treated advanced Non-Small Cell Lung Cancer (NSCLC)
    Thomas, M.
    Kohlhaeufl, M.
    Reck, M.
    Engel-Riedel, W.
    Kortsik, C.
    Bullinger, L.
    Schneider, C. -P.
    Felip, E.
    Brahmer, J.
    Vokes, E.
    Gettinger, S.
    Geese, W.
    Yoon, D.
    Healey, D.
    Li, A.
    Eberhardt, W. E. E.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 137 - 137
12345